Relentless for the

Cures

2000 Annual Report

Our

Cure leukemia, lymphoma, Hodgkin’s

missi

disease and myeloma, and improve the quality of life of patients and their families.

Our name We added the word “lymphoma” to our name last year to bring into focus the full scope of our mission–fighting all hematological malignancies. The Society was further motivated by a startling rise in lymphoma incidence rates over the last two decades. For all these blood-related cancers, we have been, and will continue to be, relentless for the cures. w w w. l e u k e m i a - l y m p h o m a . o r g

Survival rates

3

Survival rates 14%

Leukemia

31%

Non-Hodgkin’s Lymphoma

52% 40%

Hodgkin’s Disease

100%

90%

80%

70%

60%

50%

40%

Lymphoma We’re winning the battle… The fiveyear survival rate for non-Hodgkin’s lymphoma patients rose from 31% in 1960 to 52% in 1995. In children, the five-year survival rate is 78%, a significant improvement in the last 30 years.

1960

30%

But the war isn’t over…This year in the U.S., an estimated 30,800 new cases of leukemia will be diagnosed, and approximately 21,700 people will die from the disease.

28% 20%

Leukemia We’re winning the battle…The fiveyear survival rate for leukemia patients has tripled from 14% in 1960, to 44% in 1995. The five-year survival rate for children with acute lymphocytic leukemia is 81%.